Karl John Mortley Hanf

Title: Karl John Mortley Hanf: Innovator in Antibody Development

Introduction

Karl John Mortley Hanf is a notable inventor based in Billerica, MA (US). He has made significant contributions to the field of biotechnology, particularly in the development of therapeutic antibodies. His work focuses on innovative solutions for treating serious medical conditions.

Latest Patents

Hanf holds a patent for "Anti-VLA-4 antibodies having reduced effector function." This invention relates to anti-VLA-4 antibodies and their binding fragments. It also includes polynucleotides encoding these antibodies and methods for manufacturing them. Furthermore, the invention outlines methods for treating patients suffering from multiple sclerosis and epilepsy through the administration of these antibodies. Additionally, it describes methods for reducing susceptibility to scrambling of a recombinant anti-alpha 4 antibody or its binding fragments.

Career Highlights

Karl John Mortley Hanf is associated with Biogen MA Inc., a leading biotechnology company. His work at Biogen has allowed him to contribute to groundbreaking research and development in the field of therapeutic antibodies. His innovative approach has positioned him as a key figure in the industry.

Collaborations

Hanf has collaborated with several esteemed colleagues, including Ellen Garber Stark and Janine Lisa Ferrant-Orgettas. These collaborations have further enhanced the impact of his research and innovations.

Conclusion

Karl John Mortley Hanf is a prominent inventor whose work in antibody development has the potential to transform treatments for multiple sclerosis and epilepsy. His contributions to biotechnology continue to pave the way for future innovations in the field.